Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:46 PM
Ignite Modification Date:
2025-12-24 @ 7:46 PM
NCT ID:
NCT00043303
Eligibility Criteria:
* Men or women 18 to 75 years
* Chronic hepatitis C infection based on a history of positive anti-HCV antibody and/or HCV RNA
* History of prior treatment with interferon-a-based therapies or an assessment by the investigator that the patient would not benefit from interferon-a-based therapy or that treatment with interferon-a is contraindicated
* Stage 4, 5 or 6 liver fibrosis according to the Ishak scoring system.
* Cannot have presence of clinically evident ascites requiring active diuretic therapy, history of or therapy for hepatic encephalopathy, or history of GI variceal bleeding within the last 2 years (diuretic therapy of stable mild-to-moderate peripheral edema is permitted)
* Must meet minimum blood chemistry requirements
* Cannot have unstable or uncontrolled thyroid disease
* Cannot have a variety of other diseases (listed in protocol
* Other conditions for enrollment exist which would be discussed with a Clinician upon screening for the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00043303
Study Brief:
Protocol Section:
NCT00043303